Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L Choi

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Oncogene|January 24, 2008
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerK A Kwei, Y H Kim, L Girard, et al.
Oncogene|April 20, 2010
Array-based genomic resequencing of human leukemiaY Yamashita, J Yuan, I Suetake, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2007
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancerJ Lee, Y H Im, S H Lee, et al.
ESMO Open|September 21, 2024
Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05T-Y Kim, S Y Kim, J H Kim, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Oncogene|January 24, 2008
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerK A Kwei, Y H Kim, L Girard, et al.
Oncogene|April 20, 2010
Array-based genomic resequencing of human leukemiaY Yamashita, J Yuan, I Suetake, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2007
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancerJ Lee, Y H Im, S H Lee, et al.
ESMO Open|September 21, 2024
Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05T-Y Kim, S Y Kim, J H Kim, et al.
Pageof 6